Codice QR

Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future

The discovery of the mechanism underlying allergic disease, mouse models of asthma, and bronchoscopy studies provided initial insights into the role of Th2-type cytokines, including interlukin (IL)-4, IL-5 and IL-13, which became the target of monoclonal antibody therapy. Omalizumab, Benralizumab, M...

Descrizione completa

Salvato in:
Autori principali: Fernando Ramírez-Jiménez, Gandhi Fernando Pavón-Romero, Juancarlos Manuel Velásquez-Rodríguez, Mariana Itzel López-Garza, José Fernando Lazarini-Ruiz, Katia Vanessa Gutiérrez-Quiroz, Luis M. Teran
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2023-02-01
Serie:Pharmaceuticals
Soggetti:
asthma
biologic therapies
monoclonal antibodies
cytokines
chemokines
Accesso online:https://www.mdpi.com/1424-8247/16/2/270
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi